US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

fentaNYL in 0.9% sodium chloride

Reason Lack of assurance of sterility:

Central Admixture Pharmacy Services Inc NDC 71286-2071-7 D-0001-2024
Class I · High risk Terminated

Betaxolol Tablets

Reason Presence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.

KVK-Tech, Inc. NDC 10702-013-01 D-0049-2024
Class III · Low risk Terminated

Eligard

Reason Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.

Tolmar, Inc. NDC 62935-753-75 D-1178-2023
Class I · High risk Ongoing

SANDIMMUNE Oral Solution

Reason Crystallization: bottles of Sandimmune Oral Solution were determined to contain crystals.

Novartis Pharmaceuticals Corp. NDC 0078-0110-22 D-1174-2023
Class I · High risk Ongoing

TheraBreath for Kids! Oral Rinse

Reason Microbial contamination of Non-Sterile Product; presence of yeast identified as Candida parapsilosis

Church & Dwight Inc D-0046-2024
Class III · Low risk Terminated

Cequa

Reason Subpotent: Out of Specification result observed for low assay

Sun Pharmaceutical Industries INC NDC 47335-506-96 D-1172-2023
Class II · Moderate risk Terminated

Pantoprazole Sodium for Injection 40mg per vial

Reason Lack of Assurance of Sterility: Powder discoloration due to small crack in some vials.

Be Pharmaceuticals Ag NDC 71839-122-01 D-1148-2023
Class II · Moderate risk Ongoing

octiq Lubricating Eye Drops

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1167-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1166-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1165-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1164-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1163-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1162-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1161-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1159-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1158-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1157-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1156-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1155-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1154-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1153-2023
Class II · Moderate risk Ongoing

TRP Natural Eyes

Reason Lack of Assurance of Sterility

Amman Pharmaceutical Industries D-1152-2023